Paper8911291
Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.
Nickel JC and 6 others. CMAJ, 1996. Cited by 187 papers, by iCite.
Cite this record
ConductScience Library. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study. Papers, record 8911291. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8911291
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enzyme Inhibitors | Major topic |
| Finasteride | Major topic |
| Prostatic Hyperplasia | Major topic |
| Aged | |
| Aged, 80 and over | |
| Canada | |
| Double-Blind Method | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Safety | |
| Urination |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 9099163 | Managing benign prostatic hyperplasia. | https://conductscience.org/library/papers/9099163 |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2428671 | Comparison of the alpha-adrenoceptor characteristics in human and canine prostate. | Fed Proc | 1986 | https://conductscience.org/library/papers/2428671 | PubMed |
| 2 | 4130099 | A urodynamic view of prostatic obstruction and the results of prostatectomy. | Br J Urol | 1973 | https://conductscience.org/library/papers/4130099 | PubMed |
| 3 | 4413434 | Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. | N Engl J Med | 1974 | https://conductscience.org/library/papers/4413434 | PubMed |
| 4 | 8633398 | A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia. | Urology | 1996 | https://conductscience.org/library/papers/8633398 | PubMed |
| 5 | 8558668 | Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. | J Urol | 1996 | https://conductscience.org/library/papers/8558668 | PubMed |
| 6 | 7527493 | A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. | N Engl J Med | 1995 | https://conductscience.org/library/papers/7527493 | PubMed |
| 7 | 7510911 | Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia. | Urology | 1994 | https://conductscience.org/library/papers/7510911 | PubMed |
| 8 | 7505563 | Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group. | Arch Intern Med | 1994 | https://conductscience.org/library/papers/7505563 | PubMed |
| 9 | 7686980 | Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. | J Urol | 1993 | https://conductscience.org/library/papers/7686980 | PubMed |
| 10 | 1283370 | Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia. | Eur Urol | 1992 | https://conductscience.org/library/papers/1283370 | PubMed |
| 11 | 1383816 | The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1383816 | PubMed |
| 12 | 2643719 | Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. | J Urol | 1989 | https://conductscience.org/library/papers/2643719 | PubMed |
| 13 | 4384673 | The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro. | J Biol Chem | 1968 | https://conductscience.org/library/papers/4384673 | PubMed |
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 187 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42492846 | Steroid 5α-reductases in the brain: From neurosteroidogenesis to therapeutic implications. | Front Neuroendocrinol | 2026 | https://conductscience.org/library/papers/42492846 | PubMed |
| 42041803 | Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment. | Brain Sci | 2026 | https://conductscience.org/library/papers/42041803 | PubMed |
| 37697052 | The post-finasteride syndrome: possible etiological mechanisms and symptoms. | Int J Impot Res | 2025 | https://conductscience.org/library/papers/37697052 | PubMed |
| 37002313 | Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study. | Sci Rep | 2023 | https://conductscience.org/library/papers/37002313 | PubMed |
| 36580423 | Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer. | Endocrinology | 2023 | https://conductscience.org/library/papers/36580423 | PubMed |
| 36086755 | Effectiveness and safety of electroacupuncture and its cotreatment with electronic moxibustion in the treatment of patients with moderate benign prostatic hyperplasia using alpha blocker: An assessor-blinded, randomized, controlled pilot study. | Medicine (Baltimore) | 2022 | https://conductscience.org/library/papers/36086755 | PubMed |
| 34949831 | The placebo and nocebo effects in functional urology. | Nat Rev Urol | 2022 | https://conductscience.org/library/papers/34949831 | PubMed |
| 34747724 | Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis. | Asian J Androl | 2022 | https://conductscience.org/library/papers/34747724 | PubMed |
| 34729231 | The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigen (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis. | Cent European J Urol | 2021 | https://conductscience.org/library/papers/34729231 | PubMed |
| 32435662 | Post-finasteride syndrome: An emerging clinical problem. | Neurobiol Stress | 2020 | https://conductscience.org/library/papers/32435662 | PubMed |
| 32314009 | The impact of 5-alpha-reductase inhibitors on mortality in a prostate cancer chemoprevention setting: a meta-analysis. | World J Urol | 2021 | https://conductscience.org/library/papers/32314009 | PubMed |
| 32124221 | Are Noninvasive Methods Comparable to Liver Biopsy in Postoperative Patients After Roux-en-Y Gastric Bypass? | Obes Surg | 2020 | https://conductscience.org/library/papers/32124221 | PubMed |
| 32052367 | Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function. | Endocrine | 2020 | https://conductscience.org/library/papers/32052367 | PubMed |
| 31272082 | Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study. | Endocr Connect | 2019 | https://conductscience.org/library/papers/31272082 | PubMed |
| 29909472 | The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health. | Curr Urol Rep | 2018 | https://conductscience.org/library/papers/29909472 | PubMed |
| 29675596 | Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin? | Endocrine | 2018 | https://conductscience.org/library/papers/29675596 | PubMed |
| 29527813 | Effect of lower urinary tract symptoms on the quality of life and sexual function of males in China, Taiwan, and South Korea: Subgroup analysis of a cross-sectional, population-based study. | Low Urin Tract Symptoms | 2019 | https://conductscience.org/library/papers/29527813 | PubMed |
| 29264229 | Medical therapy for clinical benign prostatic hyperplasia: α1 Antagonists, 5α reductase inhibitors and their combination. | Asian J Urol | 2017 | https://conductscience.org/library/papers/29264229 | PubMed |
| 28956697 | Annurca Apple Nutraceutical Formulation Enhances Keratin Expression in a Human Model of Skin and Promotes Hair Growth and Tropism in a Randomized Clinical Trial. | J Med Food | 2018 | https://conductscience.org/library/papers/28956697 | PubMed |
| 28232919 | Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome. | Skin Appendage Disord | 2017 | https://conductscience.org/library/papers/28232919 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8911291
GET https://conductscience.org/api/papers/v1/8911291/cited_by?page=2